Nutrition and dry eye: a systematic review

References

• Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optom Vis Sci. 2000;77(7):357–363.
   PubMed Web of Science ®Google Scholar
• Bhargava R, Kumar P. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers. Cornea. 2015;34(4):413–420.
   PubMed Web of Science ®Google Scholar
• Xie W. Recent advances in laser in situ keratomileusis-associated dry eye. Clin Exp Optom. 2016;99(2):107–112.
   PubMed Web of Science ®Google Scholar
• Sagili S, Malhotra R. Dry eyes can be exacerbated by systemic antihypertensive medication. Scott Med J. 2012;57(2):121.
   PubMedGoogle Scholar
• Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother. 2011;12(3):325–334.
   PubMed Web of Science ®Google Scholar
• Milner MS, Beckman KA, Luchs JI, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27(Suppl 1):3–47.
   PubMed Web of Science ®Google Scholar
• Kastelan S, Tomić M, Salopek-Rabatić J, et al. Diagnostic procedures and management of dry eye. Biomed Res Int. 2013;2013:309723.
   PubMed Web of Science ®Google Scholar
• Marshall LL, Roach JM. Treatment of dry eye disease. Consult Pharm. 2016;31(2):96–106.
   PubMedGoogle Scholar
• Lawrenson JG, Grzybowski A. Controversies in the use of nutritional supplements in ophthalmology. Curr Pharm Des. 2015;21(32):4667–4672.
   PubMed Web of Science ®Google Scholar
• Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye. 2010;33(2):49–54. quiz 100
   PubMed Web of Science ®Google Scholar
• Faustino JF, Ribeiro-Silva A, Dalto RF, et al. Vitamin A and the eye: an old tale for modern times. Arq Bras Oftalmol. 2016;79(1):56–61.
   PubMed Web of Science ®Google Scholar
• Akhtar S, Ahmed A, Randhawa MA, et al. Prevalence of vitamin A deficiency in south Asia: causes, outcomes, and possible remedies. J Health Popul Nutr. 2013;31(4):413–423.
   PubMed Web of Science ®Google Scholar
• Sommer A. Vitamin a deficiency and clinical disease: an historical overview. J Nutr. 2008;138(10):1835–1839.
   PubMed Web of Science ®Google Scholar
• Bhargava R, Kumar P, Arora Y. Short-term omega 3 fatty acids treatment for dry eye in young and middle-aged visual display terminal users. Eye Contact Lens. 2016;42(4):231–236.
   PubMed Web of Science ®Google Scholar
• Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial. Eur J Ophthalmol. 2009;19(3):337–342.
   PubMed Web of Science ®Google Scholar
• Gadaria-Rathod N, Dentone PG, Peskin E, et al. Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials. J Ocul Pharmacol Ther. 2013;29(9):837–841.
   PubMed Web of Science ®Google Scholar
• Galbis-Estrada C, Pinazo-Durán MD, Cantú-Dibildox J, et al. Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging. 2013;8:711–719.
   PubMed Web of Science ®Google Scholar
• Galbis-Estrada C, Pinazo-Durán MD, Martínez-Castillo S, et al. A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids. Mol Vis. 2015;21:555–567.
   PubMed Web of Science ®Google Scholar
• Gatell-Tortajada J. Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study. Clin Interv Aging. 2016;11:571–578.
   PubMedGoogle Scholar
• Jalbert I. Diet, nutraceuticals and the tear film. Exp Eye Res. 2013;117:138–146.
   PubMed Web of Science ®Google Scholar
• Kawakita T, Kawabata F, Tsuji T, et al. Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomed Res. 2013;34(5):215–220.
   PubMed Web of Science ®Google Scholar
• McCusker MM, Durrani K, Payette MJ, et al. An eye on nutrition: the role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract. Clin Dermatol. 2016;34(2):276–285.
   PubMed Web of Science ®Google Scholar
• Mohammadpour M, Mehrabi S, Hassanpoor N, et al. Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial. J Curr Ophthalmol. 2017;29(1):33–38.
   PubMed Web of Science ®Google Scholar
• Nebbioso M, Rusciano D, Pucci B, et al. Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial. Eur Rev Med Pharmacol Sci. 2013;17(8):1117–1122.
   PubMed Web of Science ®Google Scholar
• Wojtowicz JC, Butovich I, Uchiyama E, et al. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30(3):308–314.
   PubMed Web of Science ®Google Scholar
• Panic N, Leoncini E, de Belvis G, et al. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One. 2013;8(12):e83138.
   PubMed Web of Science ®Google Scholar
• Bernardo WM, Nobre MR, Jatene FB. [Evidence-based clinical practice. Part II–searching evidence databases]. Rev Assoc Med Bras. 1992 2004;50(1): 104–108.
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Edinburgh: SIGN; 2012. Available from: http://www.sign.ac.uk
   Google Scholar
• Larmo PS, Jarvinen RL, Setala NL, et al. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. J Nutr. 2010 Aug;140(8):1462–1468.
   PubMed Web of Science ®Google Scholar
• Hom MM, Asbell P, Barry B. Omegas and dry eye: more knowledge, more questions. Optom Vis Sci. 2015;92(9):948–956.
   PubMed Web of Science ®Google Scholar
• Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol. 2011;22(4):279–282.
   PubMed Web of Science ®Google Scholar
• Cortina MS, Bazan HE. Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011;14(2):132–137.
   PubMed Web of Science ®Google Scholar
• Hitoe S, Tanaka J, Shimoda H. MaquiBright standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial. Panminerva Med. 2014;56(3 Suppl 1):1–6.
   PubMedGoogle Scholar
• Barabino S, Rolando M, Nardi M, et al. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. Eur J Ophthalmol. 2014;24(2):173–178.
   PubMed Web of Science ®Google Scholar
• Seitsalo H, Niemelä RK, Marinescu-Gava M, et al. Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjogren’s syndrome: a randomized, double-blind, placebo controlled cross-over study. J Negat Results Biomed. 2007;6:11.
   PubMedGoogle Scholar
• Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Topical and systemic medications for the treatment of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2012;8(7):399–411.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Fujimoto T, Nonomura A, et al. Usefulness of initial histological features for stratifying Sjogren’s syndrome responders to mizoribine therapy. Rheumatology (Oxford). 2009;48(10):1279–1282.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Saito K, Umehara H, et al. Efficacy and safety of mizoribine for the treatment of Sjogren’s syndrome: a multicenter open-label clinical trial. Mod Rheumatol. 2007;17(6):464–469.
   PubMedGoogle Scholar
• Alpoz E, Güneri P, Onder G, et al. The efficacy of Xialine in patients with Sjogren’s syndrome: a single-blind, cross-over study. Clin Oral Investig. 2008;12(2):165–172.
   PubMed Web of Science ®Google Scholar
• Yamada H, Nakagawa Y, Wakamatsu E, et al. Efficacy prediction of cevimeline in patients with Sjogren’s syndrome. Clin Rheumatol. 2007;26(8):1320–1327.
   PubMed Web of Science ®Google Scholar
• Dry Eye A, Asbell PA, Maguire MG, et al. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378(18):1681–1690.
   PubMed Web of Science ®Google Scholar
• Garcia-Carrasco M, Jiménez-Herrera EA, Gálvez-Romero JL, et al. Vitamin D and Sjogren syndrome. Autoimmun Rev. 2017;16(6):587–593.
   PubMed Web of Science ®Google Scholar
• Yang CH, Albietz J, Harkin DG, et al. Impact of oral vitamin D supplementation on the ocular surface in people with dry eye and/or low serum vitamin D. Cont Lens Anterior Eye. 2018;41(1):69–76.
   PubMed Web of Science ®Google Scholar
• Roh HC, Lee JK, Kim M, et al. Systemic comorbidities of dry eye syndrome: the Korean national health and nutrition examination survey V, 2010 to 2012. Cornea. 2016;35(2):187–192.
   PubMed Web of Science ®Google Scholar
• Epitropoulos AT, Donnenfeld ED, Shah ZA, et al. Effect of oral re-esterified omega-3 nutritional supplementation on dry eyes. Cornea. 2016;35(9):1185–1191.
   PubMed Web of Science ®Google Scholar
• Ngo W, Srinivasan S, Houtman D, et al. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals. J Optom. 2017;10(1):26–33.
   PubMedGoogle Scholar
• Butovich IA. On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Invest Ophthalmol Vis Sci. 2008;49(9):3779–3789.
   PubMed Web of Science ®Google Scholar
• Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:336–356.
   PubMedGoogle Scholar
• Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3(1):1–7.
   PubMed Web of Science ®Google Scholar
• Pinna A, Blasetti F, Zinellu A, et al. Meibomian gland dysfunction and hypercholesterolemia. Ophthalmology. 2013;120(12):2385–2389.
   PubMed Web of Science ®Google Scholar
• King-Smith PE, Hinel EA, Nichols JJ. Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning. Invest Ophthalmol Vis Sci. 2010;51(5):2418–2423.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Goto E, Dogru M, et al. Tear film lipid layer alterations in allergic conjunctivitis. Cornea. 2006;25(3):277–280.
   PubMed Web of Science ®Google Scholar
• King-Smith PE, Reuter KS, Braun RJ, et al. Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images. Invest Ophthalmol Vis Sci. 2013;54(7):4900–4909.
   PubMed Web of Science ®Google Scholar
• Fenner BJ, Tong L. More to stable tears than thickness of the tear film lipid layer. Invest Ophthalmol Vis Sci. 2015;56(3):1601.
   PubMed Web of Science ®Google Scholar
• Finis D, Pischel N, Schrader S, et al. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea. 2013;32(12):1549–1553.
   PubMed Web of Science ®Google Scholar
• Giraldez MJ, Naroo SA, Resua CG. A preliminary investigation into the relationship between ocular surface temperature and lipid layer thickness. Cont Lens Anterior Eye. 2009;32(4):177–180. quiz 193, 195
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495–505.
   PubMed Web of Science ®Google Scholar
• Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf. 2010;8(1):18–28.
   PubMed Web of Science ®Google Scholar
• Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003;38(4):343–352.
   PubMed Web of Science ®Google Scholar
• Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21–36.
   PubMed Web of Science ®Google Scholar
• Pinazo-Duran MD, Galbis-Estrada C, Pons-Vázquez S, et al. Effects of a nutraceutical formulation based on the combination of antioxidants and omega-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging. 2013;8:139–148.
   PubMed Web of Science ®Google Scholar
• Pinna A, Piccinini P, Carta F. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction. Cornea. 2007;26(3):260–264.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. The mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J Nutr. 2001;131(11 Suppl):3065S–73S.
   PubMed Web of Science ®Google Scholar
• Aragona P, Bucolo C, Spinella R, et al. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren’s syndrome patients. Invest Ophthalmol Vis Sci. 2005;46(12):4474–4479.
   PubMed Web of Science ®Google Scholar
• Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011;89(7):e591–7.
   PubMed Web of Science ®Google Scholar
• Miljanovic B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82(4):887–893.
   PubMed Web of Science ®Google Scholar
• Dyerberg J, Madsen P, Møller JM, et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137–141.
   PubMed Web of Science ®Google Scholar
• Zhu W, Wu Y, Li G, et al. Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials. Nutr Rev. 2014;72(10):662–671.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621.
   PubMedGoogle Scholar
• Creuzot-Garcher C, Baudouin C, Labetoulle M, et al. [Efficacy assessment of Nutrilarm(R), a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome]. J Fr Ophtalmol. 2011;34(7):448–455.
   PubMed Web of Science ®Google Scholar
• Jeon DH, Yeom H, Yang J, et al. Are serum vitamin D levels associated with dry eye disease? Results from the study group for environmental eye disease. J Prev Med Public Health. 2017;50(6):369–376.
   PubMedGoogle Scholar
• Liu A, Ji J. Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit. 2014;20:1583–1589.
   PubMed Web of Science ®Google Scholar